ARGENX SE

ARGX
Real-time Euronext Bruxelles - 11:35 2022-12-07 am EST
368.10 EUR -1.21%

Turn to zoom
Prev.372.60000000
Open373.40000000
High376.10000000
Low367.80000000
Volume76 050
Latest news
2h ago
2d ago
6d ago
6d ago
Chart ARGENX SE
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance395395393
Spread/Res.-6,8%-6,8%-6,4%
Spread/Supp.6,5%18%25%
Support346313295
Financials
Sales 2022 425 M 447 M 447 M
Net income 2022 -809 M -852 M -852 M
Net cash 2022 1 746 M 1 837 M 1 837 M
P/E ratio 2022 -26,1x
Yield 2022 -
Capitalization 20 614 M 21 685 M 21 685 M
EV / Sales 2022 44,4x
EV / Sales 2023 23,1x
Nbr of Employees 650
Free-Float 100%
Company
argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a...
Sector :
Bio Therapeutic Drugs
Calendar :
2023-03-02 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 372,60 €
Average target price 445,96 €
Spread / Average Target 19,7%